The perils of gene patents

Steven L Salzberg

doi:10.1038/clpt.2012.6

The perils of gene patents

Steven L Salzberg

School of Medicine

Research output: Contribution to journal › Article

Abstract

I argue here that gene patents, and patented genetic tests based on them, are a very bad idea. First, I discuss whether genes can reasonably be the subject of patents in the first place; I maintain that the answer is no. Second, I explain how gene patents interfere with scientific progress, slowing down the development of new cures and treatments for genetic diseases.

Original language	English (US)
Pages (from-to)	969-971
Number of pages	3
Journal	Clinical Pharmacology and Therapeutics
Volume	91
Issue number	6
DOIs	https://doi.org/10.1038/clpt.2012.6
State	Published - Jun 2012

Fingerprint

Patents

Genes

Inborn Genetic Diseases

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Cite this

Salzberg, S. L. (2012). The perils of gene patents. Clinical Pharmacology and Therapeutics, 91(6), 969-971. https://doi.org/10.1038/clpt.2012.6

The perils of gene patents. / Salzberg, Steven L.

In: Clinical Pharmacology and Therapeutics, Vol. 91, No. 6, 06.2012, p. 969-971.

Research output: Contribution to journal › Article

Salzberg, SL 2012, 'The perils of gene patents', Clinical Pharmacology and Therapeutics, vol. 91, no. 6, pp. 969-971. https://doi.org/10.1038/clpt.2012.6

Salzberg SL. The perils of gene patents. Clinical Pharmacology and Therapeutics. 2012 Jun;91(6):969-971. https://doi.org/10.1038/clpt.2012.6

Salzberg, Steven L. / The perils of gene patents. In: Clinical Pharmacology and Therapeutics. 2012 ; Vol. 91, No. 6. pp. 969-971.

@article{b2ec536a3ba64d7f9231de963c8ec6e6,

title = "The perils of gene patents",

abstract = "I argue here that gene patents, and patented genetic tests based on them, are a very bad idea. First, I discuss whether genes can reasonably be the subject of patents in the first place; I maintain that the answer is no. Second, I explain how gene patents interfere with scientific progress, slowing down the development of new cures and treatments for genetic diseases.",

author = "Salzberg, {Steven L}",

year = "2012",

month = "6",

doi = "10.1038/clpt.2012.6",

language = "English (US)",

volume = "91",

pages = "969--971",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Nature Publishing Group",

number = "6",

}

TY - JOUR

T1 - The perils of gene patents

AU - Salzberg, Steven L

PY - 2012/6

Y1 - 2012/6

N2 - I argue here that gene patents, and patented genetic tests based on them, are a very bad idea. First, I discuss whether genes can reasonably be the subject of patents in the first place; I maintain that the answer is no. Second, I explain how gene patents interfere with scientific progress, slowing down the development of new cures and treatments for genetic diseases.

AB - I argue here that gene patents, and patented genetic tests based on them, are a very bad idea. First, I discuss whether genes can reasonably be the subject of patents in the first place; I maintain that the answer is no. Second, I explain how gene patents interfere with scientific progress, slowing down the development of new cures and treatments for genetic diseases.

UR - http://www.scopus.com/inward/record.url?scp=84861401540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861401540&partnerID=8YFLogxK

U2 - 10.1038/clpt.2012.6

DO - 10.1038/clpt.2012.6

M3 - Article

C2 - 22609909

AN - SCOPUS:84861401540

VL - 91

SP - 969

EP - 971

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 6

ER -

Access to Document

10.1038/clpt.2012.6